| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 04/25/2012 | CN101838207B Intermediates of Entecavir and synthesis method thereof |
| 04/25/2012 | CN101511831B 作为a2a受体激动剂的腺苷衍生物 As the derivatives of adenosine a2a agonist |
| 04/25/2012 | CN101181277B 含核苷酸类似物的组合物及其合成方法 Compositions containing nucleotide analogs and synthetic methods |
| 04/24/2012 | US8163762 Purine derivatives having, in particular, anti-proliferative properties, and their biological uses |
| 04/24/2012 | US8163754 Purine derivatives for use as adenosine A-2A receptor agonists |
| 04/24/2012 | US8163479 Specific substrates for O6-alkylguanine-DNA alkyltransferase |
| 04/19/2012 | WO2012051296A2 Purine-based triazoles |
| 04/19/2012 | WO2012048417A1 Inhibitors of p75 receptor and their uses |
| 04/19/2012 | US20120095077 Methods and compositions related to modified guanine bases for controlling off-target effects in rna interference |
| 04/19/2012 | US20120095027 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 04/19/2012 | US20120095013 Use of kmup-3 for myocardial infarction |
| 04/19/2012 | US20120095006 Treatment of pulmonary hypertension |
| 04/19/2012 | US20120094999 Egfr inhibitors and methods of treating disorders |
| 04/19/2012 | US20120094972 Heterocyclic compounds and their uses |
| 04/19/2012 | CA2814540A1 Inhibitors of p75 receptor and their uses |
| 04/18/2012 | EP2440560A1 The succinate of tenofovir disoproxil |
| 04/18/2012 | EP2440559A2 Egfr inhibitors and methods of treating disorders |
| 04/18/2012 | EP2173350B1 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 04/18/2012 | CN102417508A 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 A fused aryl and heteroaryl metabolic modulators aryl derivatives and the prevention and treatment of disorders associated therewith |
| 04/18/2012 | CN102417506A 一种抗病毒药物恩替卡韦的制备方法 An antiviral drug entecavir preparation |
| 04/18/2012 | CN101838270B Intermediates of Entecavir and preparation thereof |
| 04/18/2012 | CN101522680B 制备阿巴卡韦的方法 The process for the preparation of abacavir |
| 04/17/2012 | US8158635 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 04/17/2012 | US8158634 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 04/17/2012 | US8158624 Purine PI3K inhibitor compounds and methods of use |
| 04/17/2012 | US8158604 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| 04/17/2012 | US8158376 Bisubstrate fluorescent probe binding to protein kinases |
| 04/12/2012 | US20120088771 Tissue-nonspecific alkaline phosphatase (tnap): a therapeutic target for arterial calcification |
| 04/12/2012 | US20120088765 Purine derivative and antitumor agent using same |
| 04/11/2012 | EP2438068A1 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives |
| 04/11/2012 | EP1724258B1 Heteroarylphenylurea derivative |
| 04/10/2012 | US8153640 Reverse transcriptase inhibitors; use against HIV with drug resistance to NNRTI's (Non Nucleoside Reverse Transcriptase Inhibitor drugs); Diaryl Pyrrolo(2,3-d)pyrimidines, diaryl purines, diaryl v-triazolo(4,5-d)pyrimidines |
| 04/10/2012 | US8153628 Pyrazolyl substituted xanthines |
| 04/10/2012 | CA2238843C Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof |
| 04/05/2012 | WO2012043730A1 Morpholino nucleic acid derivative |
| 04/05/2012 | US20120083502 Heterocyclic compounds and their uses |
| 04/05/2012 | US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists |
| 04/05/2012 | CA2813183A1 Morpholino nucleic acid derivatives |
| 04/04/2012 | EP1881984B1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/04/2012 | CN102405217A Azaazulene compounds |
| 04/03/2012 | US8148371 Adenine compound and use thereof |
| 03/29/2012 | WO2012038081A1 Substituted benzamide compounds |
| 03/29/2012 | US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists |
| 03/29/2012 | US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors |
| 03/29/2012 | CA2811796A1 Substituted benzamide compounds |
| 03/28/2012 | EP2433941A1 Process for isolating the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
| 03/28/2012 | CN102391267A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 03/27/2012 | US8143264 Xanthine derivatives as selective HM74A agonists |
| 03/27/2012 | US8143249 Prodrugs of A2B adenosine receptor antagonists |
| 03/22/2012 | WO2012037498A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 03/22/2012 | WO2012037226A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 03/22/2012 | WO2012037204A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 03/22/2012 | WO2012035548A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 03/22/2012 | WO2011130557A3 Phosphonates with reduced toxicity for treatment of viral infections |
| 03/22/2012 | US20120071657 Triazole compounds useful as protein kinase inhibitors |
| 03/22/2012 | US20120071490 P70 s6 kinase inhibitors |
| 03/22/2012 | US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 03/22/2012 | US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives |
| 03/22/2012 | CA2812091A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 03/22/2012 | CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 03/22/2012 | CA2811265A1 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction |
| 03/22/2012 | CA2810625A1 Purine compounds as prodrugs of a2b adenosine receptor antagonists, their process and medicinal applications |
| 03/21/2012 | CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 03/20/2012 | US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 03/20/2012 | US8138172 8-oxoadenine derivatives acting as modulators of TLR7 |
| 03/15/2012 | WO2012034132A2 Inhibitors of human ezh2, and methods of use thereof |
| 03/15/2012 | WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 03/15/2012 | WO2012031574A1 Use of 6 - substituted 9 - halogenalkyl purines for regulation of growth and development of whole plants, plant cells and plant organs; novel 6 - substituted 9 -halogenalkyl purines |
| 03/15/2012 | WO2012031445A1 Processes for preparing piperazinium salts of kmup and use thereof |
| 03/15/2012 | US20120065364 Peptide nucleic acid monomers and oligomers |
| 03/15/2012 | CA2811025A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 03/15/2012 | CA2810998A1 Inhibitors of human ezh2, and methods of use thereof |
| 03/14/2012 | EP2078018B1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 03/14/2012 | EP2013211B1 Purine derivatives for use as adenosin a2a receptor agonists |
| 03/14/2012 | CN202164252U 一种2,9-二乙酰基鸟嘌呤合成后的处理装置 One kind of 2,9-diacetyl-processing apparatus after the synthesis of guanine |
| 03/14/2012 | CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors |
| 03/08/2012 | WO2012031073A1 Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
| 03/08/2012 | WO2012031072A1 Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation |
| 03/08/2012 | WO2012031068A1 Method of utilizing recycled deuterium oxide in the synthesis of deuterated compounds |
| 03/08/2012 | WO2012029068A2 Antioxident substituted coffee |
| 03/08/2012 | US20120059001 Novel kinase modulators |
| 03/07/2012 | EP2426130A1 Purine derivative and antitumor agent using same |
| 03/07/2012 | EP2424859A1 Inhibitors of pi3 kinase and / or mtor |
| 03/07/2012 | EP2175859B1 Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
| 03/07/2012 | EP1467990B1 Process for producing dioxolane nucleoside analogue precursors |
| 03/07/2012 | CN102369204A 3-deazaneplanocin derivatives |
| 03/07/2012 | CN102367254A More stable doxofylline compound and pharmaceutical composite thereof |
| 03/01/2012 | US20120053191 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 02/29/2012 | CN102365283A Novel crystal forms of adefovir dipivoxil and processes for preparing the same |
| 02/28/2012 | US8124653 Controlled, sustained and/or time release tetrahydrobiopterin formulations; phenylketonuria; optionally with methylphenidate, clonidine, amphetamine and/or pemoline |
| 02/28/2012 | US8124609 Acyclic nucleoside derivatives |
| 02/28/2012 | US8124417 Method for analyzing nucleobases on a single molecular basis |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/22/2012 | EP1891071B1 Cyclopropanecarboxylate esters of acyclovir |
| 02/22/2012 | EP1626049B1 Microcrystal of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione |
| 02/22/2012 | EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus |
| 02/22/2012 | CN102358740A Process for extracting caffeine from tea |
| 02/22/2012 | CN101701026B 一种鸟苷催化裂解方法 One kind of guanosine catalytic cracking process |
| 02/21/2012 | US8119648 Arthritis, obesity, (non-insulin dependent) diabetes calcitonin-induced osteoporosis; administering allograft transplantation; dipeptidyl peptidase-IV (DPP-IV) inhibitors |
| 02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |